Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYK2 | P29597 | 20/20 | 0.58 |
| ▸ | JAK3 | P52333 | 20/20 | 0.58 |
| ▸ | JAK2 | O60674 | 18/20 | 0.58 |
| ▸ | JAK1 | P23458 | 18/20 | 0.58 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.48 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23878845 | 1.00 | TYK2 (0.58) | TYK2JAK3JAK2JAK1P2RX3 | |
| SCHEMBL22054114 | 1.00 | TYK2 (0.58) | TYK2JAK3JAK2JAK1P2RX3 | |
| SCHEMBL29565856 | 0.88 | TYK2 (0.75) | TYK2JAK3JAK2JAK1P2RX3 | |
| SCHEMBL18269689 | 0.88 | TYK2 (0.75) | TYK2JAK3JAK2JAK1P2RX3 | |
| SCHEMBL29512168 | 0.88 | TYK2 (0.75) | TYK2JAK3JAK2JAK1P2RX3 | |
| SCHEMBL26323063 | 0.85 | JAK3 (0.78) | TYK2JAK3JAK2JAK1P2RX3 | |
| SCHEMBL23889360 | 0.84 | TYK2 (0.50) | TYK2JAK3JAK2JAK1P2RX3 | |
| SCHEMBL24337129 | 0.83 | TYK2 (0.57) | TYK2JAK3JAK2JAK1 | |
| SCHEMBL18260488 | 0.83 | TYK2 (0.69) | TYK2JAK3JAK2JAK1 | |
| SCHEMBL18269700 | 0.83 | TYK2 (0.58) | TYK2JAK3JAK2JAK1P2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116003441-B | Heteroaromatic derivative regulator, preparation method and application thereof | 江苏豪森药业集团有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-115925705-B | Heteroaromatic derivative regulator, preparation method and application thereof | 江苏豪森药业集团有限公司 | 2024-12-31 | — | — | CN | disclosed |